Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
131.84
-1.13 (-0.85%)
Apr 29, 2026, 3:29 PM IST
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 3.15 billion as of April 29, 2026. Its market cap has increased by 79.57% in one year.
Market Cap
3.15B
Enterprise Value
3.47B
Revenue
1.47B
Ranking
n/a
PE Ratio
32.53
Stock Price
131.84
Market Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 3.15B, an increase of 28,806.52%. That is a compound annual growth rate of 150.95%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valiant Laboratories | 4.11B |
| Nectar Lifesciences | 2.29B |
| Brooks Laboratories | 1.99B |
| Alpa Laboratories | 1.44B |
| Sigachi Industries | 8.39B |
| Par Drugs and Chemicals | 1.12B |
| Vaishali Pharma | 1.05B |
| Ind-Swift Laboratories | 11.91B |